← Leaderboards
Simon Hsu
University Of Washington
$654,087
Attributed
$654,087
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $187.7K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$654,087 · 2
By mechanism
K23$560,734 · 1
F32$93,353 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Mary L. Disis$210,448,010
- Ian H De Boer$19,396,846
- Dennis M Donovan$35,213,977
- Bryan R Kestenbaum$15,927,099
- Margaret McLean Heitkemper$19,105,705
Others in their field
Other Emerging Leaders on “Cardiovascular Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- Susan M Landau · University Of California Berkeley$47,252,026
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,835,254
- Bradley G Hammill · Duke University$15,773,864
Research focus
Cardiovascular DiseasesVitamin D3 ReceptorPth GeneParticipantSerumVitamin DClinical TrialsFoundationsKidneyOralChronic Kidney FailureResearch PersonnelStructureTrainingCardiovascular Disorder RiskClinical PracticeEventBone DiseasesFutureIntravenousMetabolismMineralsCostBiomarker Panel
Grant awards (5)
Comparative Safety and Efficacy of Low-dose Vitamin D in Kidney Failure$186,516
K23 · FY2025 · DK · contact PI
Comparative Safety and Efficacy of Low-dose Vitamin D in Kidney Failure$186,516
K23 · FY2024 · DK · contact PI
Comparative Safety and Efficacy of Low-dose Vitamin D in Kidney Failure$187,702
K23 · FY2023 · DK · contact PI
F32 Childcare Costs Supplement: Assessment of the Vitamin D Metabolite Ratio as a Therapeutic Target in Clinical Practice$2,500
F32 · FY2022 · DK · contact PI
Assessment of the Vitamin D Metabolite Ratio as a Therapeutic Target in Clinical Practice$90,853
F32 · FY2021 · DK · contact PI